Otsuka Pharmaceutical is looking to banish paper from clinical trials by working to prepare a 100% e-platform for use in Phase III.
A Stanford University spinout that lists Johnson & Johnson, Novartis and Pfizer among its users has raised $10 million to develop its brain mapping…
Trialbee has added ex-Lundbeck CEO Ulf Wiinberg and former Bristol-Myers Squibb SVP Lars Birgerson to its board of directors.
Daiichi Sankyo has struck a deal to use Veeva Systems’ cloud platform to store its eTMFs and other R&D files.
Apple has bought three-year-old startup Gliimpse to build out its health data capabilities.
The rise of genome sequencing has opened a new frontier for the issue that could drive divergence of the cancer care received by different races.
Researchers have published the first analysis of the 60,000 people sequenced through the Exome Aggregation Consortium.
The Pfizer study that identified 15 genome sites linked to depression in 23andMe’s database has sparked a surge in demands to access the repository.
Researchers have enrolled 2,000 people with metastatic breast cancer in 7 months using a social media-enabled, direct-to-patient model of recruiting.
Google's Art Levinson-helmed biotech Calico has hired Daphne Koller to build and lead its computational biology and machine learning team.